Literature DB >> 31439631

Molecular basis for GIGYF-Me31B complex assembly in 4EHP-mediated translational repression.

Daniel Peter1,2, Vincenzo Ruscica1, Praveen Bawankar1,3, Ramona Weber1, Sigrun Helms1, Eugene Valkov1, Cátia Igreja1, Elisa Izaurralde1.   

Abstract

GIGYF (Grb10-interacting GYF [glycine-tyrosine-phenylalanine domain]) proteins coordinate with 4EHP (eIF4E [eukaryotic initiation factor 4E] homologous protein), the DEAD (Asp-Glu-Ala-Asp)-box helicase Me31B/DDX6, and mRNA-binding proteins to elicit transcript-specific repression. However, the underlying molecular mechanism remains unclear. Here, we report that GIGYF contains a motif necessary and sufficient for direct interaction with Me31B/DDX6. A 2.4 Å crystal structure of the GIGYF-Me31B complex reveals that this motif arranges into a coil connected to a β hairpin on binding to conserved hydrophobic patches on the Me31B RecA2 domain. Structure-guided mutants indicate that 4EHP-GIGYF-DDX6 complex assembly is required for tristetraprolin-mediated down-regulation of an AU-rich mRNA, thus revealing the molecular principles of translational repression.
© 2019 Peter et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  DEAD-box helicases; RNA regulation; translational repression

Mesh:

Substances:

Year:  2019        PMID: 31439631      PMCID: PMC6771390          DOI: 10.1101/gad.329219.119

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


Initiation of translation by the eukaryotic initiation factor 4E (eIF4E) is regulated by competitor cap-binding proteins of the eIF4E family, such as the eIF4E homologous protein (4EHP; also known as eIF4E2) (Kong and Lasko 2012). 4EHP is responsible for the assembly of translational repressor complexes that inhibit mRNA expression in different biological contexts (Cho et al. 2005, 2006; Villaescusa et al. 2009; Chapat et al. 2017). 4EHP specifically associates with Grb10-interacting GYF (glycinetyrosinephenylalanine domain) protein 1 (GIGYF1) and GIGYF2. These proteins possess an N-terminal 4EHP-binding region (4EHP-BR) and a central compacted GYF domain (Supplemental Fig. S1A; Ash et al. 2010; Peter et al. 2017) that mediates the interaction with ZNF598, tristetraprolin (TTP), or the microRNA (miRNA)-induced silencing complex-associated TNRC6 proteins (Morita et al. 2012; Fu et al. 2016; Schopp et al. 2017). These RNA-associated proteins recruit the 4EHP–GIGYF2 complex to specific mRNAs important for mouse embryonic development, cytokine mRNA expression, or repression of miRNA targets, respectively (Morita et al. 2012; Fu et al. 2016; Tollenaere et al. 2019). GIGYF proteins do not simply bridge 4EHP to the RNA-associated proteins but rather participate directly in the repression mechanism (Peter et al. 2017). Human GIGYF2 regulates the expression of a subset of mRNAs via the recruitment of the CCR4–NOT complex (Amaya Ramirez et al. 2018). GIGYF proteins also associate with DDX6 (Me31B in Drosophila melanogaster [Dm] and Dhh1p in yeast) (Amaya Ramirez et al. 2018; Ruscica et al. 2019), an important regulator of gene expression (Ostareck et al. 2014; Wang et al. 2015; Lumb et al. 2017) that acts as translational repressor and enhancer of mRNA decapping (Coller et al. 2001; Radhakrishnan et al. 2016). DDX6 orthologs are RNA-dependent ATPases of the DEAD (Asp–Glu–Ala–Asp)-box family that feature two globular RecA-like domains (RecA1 and RecA2) connected by a flexible linker. DEAD-box proteins use ATP binding and hydrolysis coupled to RNA binding to promote conformational transitions and remodeling of RNA and/or ribonucleoprotein particles (mRNPs) (Ozgur et al. 2015b). DDX6 has restricted conformational flexibility and limited ATPase activity and requires stimulation by interacting factors (Mathys et al. 2014). DDX6 assembles in mutually exclusive complexes with P-body components such as EDC3, LSM14A, PatL1, and the eIF4E transporter protein (4E-T) (Jonas and Izaurralde 2013). These proteins use different short linear motifs to associate with two binding pockets in the RecA2 domain of DDX6, referred to here as Phe–Asp–Phe (FDF) and Trp (W) pockets (Tritschler et al. 2008; Sharif et al. 2013; Ozgur et al. 2015a; Brandmann et al. 2018). To elucidate how GIGYF proteins function together with DDX6 in the regulation of mRNA expression, we determined the crystal structure of an N-terminal conserved motif from Dm GIGYF that mediates direct binding to Me31B (Fig. 1A; Supplemental Fig. S1A). This binding motif, characterized by a Pro–Glu–Trp (PEW) sequence and a “split” FDF sequence, binds to Me31B in a unique manner. We further show that recruitment of DDX6 via GIGYF2 is required in human cells for efficient translational repression of an AU-rich reporter mRNA by TTP. Collectively, these data have advanced our understanding of the molecular principles governing the assembly of mRNPs that rely on the 4EHP–GIGYF complex and DDX6 proteins to posttranscriptionally regulate gene expression.
Figure 1.

GIGYF proteins contain a conserved Me31B/DDX6-binding motif (MBM). (A) Sequence alignment of the MBM of Dm and Homo sapiens (Hs) GIGYF with the CUP homology domain (CHD) of Dm and Hs 4E-T and Dm CUP. Residues with >70% similarity are shown with a light-colored background. Conserved residues are highlighted with a darker background and are printed in white. Secondary structure elements based on the structures presented in this study are indicated above the Dm GIGYF sequence. Boxed residues highlight the PEW (green) and FDF/IEL (black) motifs. The asterisk indicates the polar residue preceding the FDF motif. (B) The binding of HA-Dm GIGYF (FL or the indicated proteins) to Me31B was analyzed in coimmunoprecipitation (co-IP) assays using anti-HA antibodies upon S2 cell transfection. HA-MBP served as a negative control. The input (1.5% for the HA proteins and 0.2% for Me31B) and immunoprecipitated (30% for the HA proteins and 45% for Me31B) fractions were analyzed by Western blotting using anti-HA and anti-Me31B antibodies. (C) The interaction between GFP-Dm Me31B (FL or the indicated RecA domains) and HA-Dm GIGYF N-terminal expressed in S2 cells was analyzed in co-IP assays using anti-GFP antibodies. GFP-MBP served as a negative control. Input (3% for the GFP proteins and 1% for the HA proteins) and immunoprecipitated (15% for the GFP proteins and 30% for the HA proteins) fractions were analyzed by Western blotting using anti-GFP and anti-HA antibodies. (D) GST pull-down assay showing the interaction between the GST-Me31B RecA2 domain and the MBP-Dm GIGYF MBM. GST served as a negative control. The starting material (6.25% for GST proteins and 2% for the MBP proteins) and bound fractions (20%) were analyzed by SDS-PAGE followed by Coomassie blue staining. The size markers (in kilodaltons) are shown at the right of each panel.

GIGYF proteins contain a conserved Me31B/DDX6-binding motif (MBM). (A) Sequence alignment of the MBM of Dm and Homo sapiens (Hs) GIGYF with the CUP homology domain (CHD) of Dm and Hs 4E-T and Dm CUP. Residues with >70% similarity are shown with a light-colored background. Conserved residues are highlighted with a darker background and are printed in white. Secondary structure elements based on the structures presented in this study are indicated above the Dm GIGYF sequence. Boxed residues highlight the PEW (green) and FDF/IEL (black) motifs. The asterisk indicates the polar residue preceding the FDF motif. (B) The binding of HA-Dm GIGYF (FL or the indicated proteins) to Me31B was analyzed in coimmunoprecipitation (co-IP) assays using anti-HA antibodies upon S2 cell transfection. HA-MBP served as a negative control. The input (1.5% for the HA proteins and 0.2% for Me31B) and immunoprecipitated (30% for the HA proteins and 45% for Me31B) fractions were analyzed by Western blotting using anti-HA and anti-Me31B antibodies. (C) The interaction between GFP-Dm Me31B (FL or the indicated RecA domains) and HA-Dm GIGYF N-terminal expressed in S2 cells was analyzed in co-IP assays using anti-GFP antibodies. GFP-MBP served as a negative control. Input (3% for the GFP proteins and 1% for the HA proteins) and immunoprecipitated (15% for the GFP proteins and 30% for the HA proteins) fractions were analyzed by Western blotting using anti-GFP and anti-HA antibodies. (D) GST pull-down assay showing the interaction between the GST-Me31B RecA2 domain and the MBP-Dm GIGYF MBM. GST served as a negative control. The starting material (6.25% for GST proteins and 2% for the MBP proteins) and bound fractions (20%) were analyzed by SDS-PAGE followed by Coomassie blue staining. The size markers (in kilodaltons) are shown at the right of each panel.

Results and Discussion

The GIGYF linear motif is necessary and sufficient to directly bind Me31B/DDX6

The GIGYF orthologs contain a short conserved sequence motif with partial similarity to the CUP homology domain (CHD) present in 4E-T proteins (Fig. 1A; Kamenska et al. 2014; Ruscica et al. 2019). Deletion of this Me31B/DDX6-binding motif (MBM) abrogated the interaction of Me31B/DDX6 with transiently expressed and tagged GIGYF (Dm GIGYF and Homo sapiens [Hs] GIGYF1/2) in Drosophila and human cells (Fig. 1B; Supplemental Fig. S1B,C; Ruscica et al. 2019). The MBM alone interacted with Me31B/DDX6 as efficiently as full-length (FL) GIGYF or the N-terminal fragment of GIGYF (Fig. 1B; Supplemental Fig. S1B,C), indicating that the MBM is necessary and sufficient for a stable interaction between the proteins. In coimmunoprecipitation (co-IP) assays, GIGYF proteins associated with the RecA2, but not the RecA1, domain of Dm Me31B and human DDX6 (Fig. 1C; Supplemental Fig. S1D,E), as observed previously for other DDX6-interacting factors (Tritschler et al. 2009; Sharif et al. 2013; Ozgur et al. 2015a; Brandmann et al. 2018). The purified recombinant GST-tagged RecA2 domain of Me31B/DDX6 associated with MBP-tagged Dm GIGYF and human GIGYF1/2 MBM by pull-down (Fig. 1D; Supplemental Fig. S1F,G). The MBM thus has a crucial role in mediating a direct and stable interaction between GIGYF and DDX6.

The Dm GIGYF MBM interacts with Me31B using a bipartite mode

We hypothesized that the GIGYF MBM binds to the W pocket of DDX6 via the conserved PEW motif because of the apparent sequence similarity to the CHD region of 4E-T (Fig. 1A; Ozgur et al. 2015a). However, the presence of alanine or serine in place of the second phenylalanine in the FDF-like motif (FDA/S) and the absence of an Ile–Glu–Leu (IEL) motif as observed in 4E-T suggest that the binding mode to the conserved hydrophobic FDF pocket of DDX6 may have diverged. To investigate this further, we determined the crystal structure of the Dm GIGYF MBM (residues D343–G369) in complex with the RecA2 domain of Me31B (residues E264–V431) to 2.4 Å resolution (Supplemental Table S1). The RecA2 domain of Me31B adopts a typical α/β-fold characterized by a central six-stranded parallel β sheet covered by α-helical layers on either side (Fig. 2A; Cheng et al. 2005). In the structure of the complex, the GIGYF MBM curves around helices α10 and α11 of Me31B to engage the conserved FDF and W pockets—known binding sites for Hs 4E-T, Hs and Saccharomyces cerevisiae (Sc) Edc3, Sc Pat1, and Hs LSM14A (Fig. 2A; Supplemental Fig. S2A–F; Tritschler et al. 2008; Sharif et al. 2013; Ozgur et al. 2015a; Brandmann et al. 2018). Two distinct structured elements can be identified in the MBM: a short coil running along helix α11 of Me31B and a β hairpin containing a “split” FDF motif (FDx4F) (Fig. 2B–D).
Figure 2.

Structure of Dm GIGYF MBM bound to Me31B. (A) Overview of the structure of the Dm GIGYF MBM in complex with the Me31B RecA2 domain. Me31B is colored in light blue, and GIGYF is in red. Selected secondary structure elements are indicated. (B) Close-up view on the PEW sequence of GIGYF at the W pocket of Me31B. (C,D) Close-up views on the interactions of the FDx4F β hairpin of GIGYF with Me31B. Selected interface residues are shown as sticks. For clarity reasons, all residues labeled with an asterisk are shown without their side chain.

Structure of Dm GIGYF MBM bound to Me31B. (A) Overview of the structure of the Dm GIGYF MBM in complex with the Me31B RecA2 domain. Me31B is colored in light blue, and GIGYF is in red. Selected secondary structure elements are indicated. (B) Close-up view on the PEW sequence of GIGYF at the W pocket of Me31B. (C,D) Close-up views on the interactions of the FDx4F β hairpin of GIGYF with Me31B. Selected interface residues are shown as sticks. For clarity reasons, all residues labeled with an asterisk are shown without their side chain. The N-terminal PEW (P347, E348, and W349) peptide trio of the GIGYF MBM initiates a short coil that inserts the aromatic side chain of W349GIGYF (equivalent to W221 in 4E-T) into the hydrophobic pocket formed by residues V283, L310, L311, and F370 between helices α10 and α11 of Me31B (Fig. 2B; Supplemental Fig. S3A). Other DDX6 interactors also feature a large aromatic residue (W91 in Sc Edc3, F192 in Hs EDC3, F42 in Sc Pat1, or F396 in Hs LSM14A) inserted at the equivalent pocket of Dhh1/DDX6 (Supplemental Figs. S3, S4A–C). Hydrogen bonding between the side chains of Q306Me31B and K314Me31B and the backbone oxygens of N345GIGYF and A350GIGYF lends additional stability to the interface (Fig. 2B). The PEW sequence of the GIGYF MBM is then connected via a flexible linker to a β-hairpin structure formed at the FDF pocket of Me31B (Fig. 2A,C,D). The β hairpin serves to orient the FDF motif (F361, D362, and F367GIGYF) to optimally engage Me31B. The F361 and F367GIGYF are in positions structurally equivalent to those observed previously in other FDF or IEL sequences (Supplemental Fig. S5; Tritschler et al. 2008; Sharif et al. 2013; Ozgur et al. 2015a; Brandmann et al. 2018). The aromatic rings of F361 and F367GIGYF are accommodated in an “edge to face” orientation stabilized by a network of hydrophobic contacts formed by residues A275, H284, C285, L289, and I421Me31B (Fig. 2C). The side chain of D362GIGYF forms hydrogen bonds to the backbone nitrogen of S364GIGYF as well as to the imidazole ring of H368GIGYF, linking the loop region to the C-terminal portion of the hairpin (Fig. 2D). G365 and F367GIGYF participate in backbone-mediated interactions with F276Me31B, thus extending the Me31B β sheet at the tip of the β8 strand (Fig. 2D). The first hairpin strand (β1) is anchored to Me31B by hydrogen bonds between the side chain of K423Me31B and the backbone oxygen of F361GIGYF (Fig. 2D). The GIGYF MBM contacts two conserved surfaces on Dm Me31B in a composite bipartite binding arrangement that combines the salient features of the 4E-T PEW motif with the FDF motif present in EDC3 and LSM14A homologs as well as Sc Pat1 (Fig. 1A; Supplemental Figs. S3, S5). Thus, despite the overall conservation of the interface and the mutually exclusive binding, GIGYF exhibits notable structural differences compared with other DDX6 interactors by using a “split” FDx4F motif.

The GIGYF FDx4F motif does not block NOT1 binding to DDX6

NOT1, the scaffold protein of the CCR4–NOT deadenylase complex, interacts with a surface of RecA2 domain adjacent to but not overlapping with the surface engaged by the other DDX6 interactors (Supplemental Fig. S2A; Chen et al. 2014; Mathys et al. 2014). Comparative structural analysis of DDX6-containing complexes indicates that the negatively charged residues preceding the FDF and DW motifs present in Hs EDC3 and PatL1 proteins (D203, F204, D205, and F206EDC3 and D43, D44, D45, and W46PatL1) (Supplemental S4A,B) are very likely to induce electrostatic repulsions to the NOT1 residues that face the DDX6 FDF pocket. This will impose a significant unfavorable energetic cost on the assembly of a ternary complex by EDC3/PatL1, DDX6, and NOT1 (Ozgur et al. 2015a). However, in the case of 4E-T, the IEL motif is preceded by a polar residue (Fig. 1A), which permits binding to the DDX6–CNOT1 complex. By analogy, GIGYF can, in principle, assemble into a ternary complex with DDX6–NOT1, as the residues located N-terminally to the FDx4F motif are polar rather than negatively charged (Fig. 1A). We have not validated this structural hypothesis in cells, but an N-terminal region of human GIGYF2 containing the MBM does bind NOT1 in co-IP assays in HeLa cells (Amaya Ramirez et al. 2018), thus providing support to the notion of the existence of a functional CNOT1–DDX6–GIGYF2 ternary complex.

The bipartite binding mode is essential for GIGYF–DDX6 complex assembly

Guided by the structural analysis of the binding interfaces, we next substituted key residues on the W (LK-AA mutant) or FDF (CL-AA mutant) pockets in Me31B/DDX6 (Supplemental Table S2; Supplemental Fig. S4D) and tested binding by co-IP following transient expression in either Dm S2 or human cells. The interaction of GIGYF (HA-Dm GIGYF or Hs GIGYF1/2) with Me31B/DDX6 was strongly impaired by individual or combined pocket mutations (Fig. 3A,B), pointing to a crucial functional role for both binding pockets in stabilizing the association between the proteins.
Figure 3.

GIGYF proteins use a bipartite binding mode to address DDX6. (A,B) Analysis of the interaction of GFP-Me31B with HA-GIGYF, 4E-T, and HPat in S2 cells (A) or of V5-SBP-DDX6 with human GIGYF1/2 and PatL1 (B). The DDX6 proteins are either wild type (WT) or the indicated mutants. GFP proteins were immunoprecipitated using anti-GFP antibodies, whereas SBP proteins were pulled down using streptavidin-coated beads. Firefly luciferase (F-Luc)-GFP and V5-SBP-MBP served as negative controls. (A) The inputs for the Dm experiment were 3% for the GFP proteins and 1% for HA-GIGYF, 4E-T, and HPat, whereas bound fractions corresponded to 15% for the GFP proteins, 30% for HA-GIGYF and 4E-T, and 20% for HPat. (B) In the pull-down assay with the human proteins, inputs were 1.25% for the V5-SBP proteins and 0.5% for GIGYF1/2 and PatL1, while bound fractions corresponded to 5% for the V5-SBP proteins and 30% for the other proteins. Samples were analyzed by Western blotting using anti-GFP, anti-HA, and anti-V5 antibodies and protein-specific antibodies. (C) The interaction between GFP-Me31B and HA-GIGYF—wild type or the indicated mutants (W* [W349A], FF* [F361A, F367A], and WFF*) (Supplemental Table S2)—was analyzed in Dm S2 cell lysates using anti-GFP co-IP. GFP-MBP served as a negative control. The input (3% for the GFP proteins and 1% for the HA proteins) and bound fractions (15% for the GFP proteins and 30% for the HA proteins) were analyzed by Western blotting using the indicated antibodies. (D) Streptavidin-based pull-down assays showing the association of SBP-V5-Hs GIGYF2—wild type or the indicated mutants (W* [W288A], FF* [F300A, F306A], and WFF*) (Supplemental Table S2)—and DDX6. V5-SBP-MBP-F-Luc-EGFP served as a negative control. The input (1.25% for the V5-SBP proteins and 0.5% for DDX6) and bound fractions (8% for the V5-SBP proteins and 30% for DDX6) were analyzed by Western blotting using the indicated antibodies.

GIGYF proteins use a bipartite binding mode to address DDX6. (A,B) Analysis of the interaction of GFP-Me31B with HA-GIGYF, 4E-T, and HPat in S2 cells (A) or of V5-SBP-DDX6 with human GIGYF1/2 and PatL1 (B). The DDX6 proteins are either wild type (WT) or the indicated mutants. GFP proteins were immunoprecipitated using anti-GFP antibodies, whereas SBP proteins were pulled down using streptavidin-coated beads. Firefly luciferase (F-Luc)-GFP and V5-SBP-MBP served as negative controls. (A) The inputs for the Dm experiment were 3% for the GFP proteins and 1% for HA-GIGYF, 4E-T, and HPat, whereas bound fractions corresponded to 15% for the GFP proteins, 30% for HA-GIGYF and 4E-T, and 20% for HPat. (B) In the pull-down assay with the human proteins, inputs were 1.25% for the V5-SBP proteins and 0.5% for GIGYF1/2 and PatL1, while bound fractions corresponded to 5% for the V5-SBP proteins and 30% for the other proteins. Samples were analyzed by Western blotting using anti-GFP, anti-HA, and anti-V5 antibodies and protein-specific antibodies. (C) The interaction between GFP-Me31B and HA-GIGYF—wild type or the indicated mutants (W* [W349A], FF* [F361A, F367A], and WFF*) (Supplemental Table S2)—was analyzed in Dm S2 cell lysates using anti-GFP co-IP. GFP-MBP served as a negative control. The input (3% for the GFP proteins and 1% for the HA proteins) and bound fractions (15% for the GFP proteins and 30% for the HA proteins) were analyzed by Western blotting using the indicated antibodies. (D) Streptavidin-based pull-down assays showing the association of SBP-V5-Hs GIGYF2—wild type or the indicated mutants (W* [W288A], FF* [F300A, F306A], and WFF*) (Supplemental Table S2)—and DDX6. V5-SBP-MBP-F-Luc-EGFP served as a negative control. The input (1.25% for the V5-SBP proteins and 0.5% for DDX6) and bound fractions (8% for the V5-SBP proteins and 30% for DDX6) were analyzed by Western blotting using the indicated antibodies. Conversely, we also analyzed the effect of amino acid substitutions in GIGYF on the interaction with DDX6. Tryptophan substitution by alanine in the PEW motif (W* mutant), of both phenylalanines in the FDx4F motif (FF* mutant), or in combination (WFF* mutant) (Supplemental Table S2) abolished the interaction of Dm and human GIGYF with Me31B/DDX6 in cells (Fig. 3C,D; Supplemental Fig. S6A). Dm HPat and human PatL1 do not contain an FDF motif but rather contain a DW sequence motif that interacts with Me31B/DDX6 (Supplemental Fig. S4A). Interestingly, the mutations in the W and FDF pockets of Me31B/DDX6 also strongly reduced binding to HPat/PatL1, which is consistent with previous observations (Fig. 3A,B; Sharif et al. 2013). However, the disruption of the FDF pocket (CL-AA mutant) did not affect the association of Me31B/DDX6 with 4E-T or LSM14A and only mildly impaired binding to EDC3 (Dm and Hs) (Fig. 3A; Supplemental Fig. S6B–D). In contrast, the substitutions in the W pocket strongly reduced binding to Dm and human 4E-T, EDC3, and LSM14A (Fig. 3A; Supplemental Fig. S6B–D). Collectively, these binding studies are consistent with a differential contribution of the two binding pockets in DDX6 toward promoting stable interactions with various factors. Reported differences in the binding affinities further support this model: Both Sc Pat1 and Sc EDC3 are high-affinity binders of Sc Dhh1 (Kd of 50 nM and 200 nM, respectively) (Sharif et al. 2013); human DDX6 interactors are rather more diverse in their affinities, with reported Kds of 230 nM for PatL1, 390 nM for 4E-T, 410 nM for EDC3, and 1.62 µM for LSM14A (Brandmann et al. 2018).

GIGYF2–DDX6 interaction contributes to TTP-mediated translational repression

To explore the functional relevance of the GIGYF–DDX6 interaction, we investigated the regulation of mRNA expression by TTP in human cells. TTP represses the expression of AU-rich transcripts via the recruitment of the 4EHP–GIGYF2 complex (Fu et al. 2016; Peter et al. 2017). To test the TTP-mediated repression in a reporter assay, we chose a Renilla luciferase (R-Luc) mRNA with two copies of the TNF-α mRNA AU-rich element (ARE) in the 3′ untranslated region (UTR) (Supplemental Fig. S7A). To distinguish the consequences of translational repression from degradation, an internal polyadenosine sequence of 90 nucleotides was “tailed” by a noncoding RNA MALAT1 sequence at the 3′ end, which is generated by RNase P endonucleolytic cleavage, rendering this reporter mRNA resistant to 5′–3′ decay (R-Luc-ARE-A90-MALAT1) (Peter et al. 2017). A plasmid encoding firefly luciferase (F-Luc-GFP) was included as a transfection and normalization control. To bypass the recruitment of DDX6 via NOT1, we transiently expressed a TTP construct lacking the NOT1-binding motif (ΔCIM) (Fabian et al. 2013). We observed that TTP ΔCIM efficiently repressed the expression of the R-Luc reporter without altering its mRNA abundance in control cells (Fig. 4A; Supplemental Fig. S7B,C). By comparison, TTP-induced translational repression was alleviated in GIGYF1/2-null cells (GIGYF1/2 knockout) even though the observed level of TTP expression was comparable with that in the control cells (Fig. 4, A,B, lane 4 vs. lane 2). In GIGYF1/2-null cells, TTP-mediated translational repression was restored by coexpression of GIGYF2 and its stabilizing partner, 4EHP (Fig. 4A,B). However, the repressive function of TTP could be selectively impaired when 4EHP was coexpressed with the GIGYF2 mutants that do not bind to DDX6 (WFF*) or TTP (GYF*) (Fig. 4A,B; Supplemental Fig. S7D). The repressive function of TTP was critically dependent on the ARE, as none of the factors influenced the expression of a reporter lacking this sequence (R-Luc-A95-MALAT1) (Supplemental Fig. S7E,F). Collectively, these data support a model in which the assembly of the 4EHP–GIGYF2–DDX6 complex is a prerequisite for TTP-mediated translational control of AU-rich transcripts.
Figure 4.

Recruitment of DDX6 by Hs GIGYF2 contributes to TTP-mediated translational repression of an ARE mRNA reporter. (A) Control or GIGYF1/2-null HEK293T cells (knockout [KO]) were transfected with the R-Luc-ARE-A90-MALAT1 reporter and plasmids expressing wild type (WT) or the indicated GIGYF2 mutants, HA-4EHP, and HA-TTP ΔCIM (Fabian et al. 2013). An F-Luc-GFP reporter served as a transfection control. R-Luc activity was normalized to that of the F-Luc transfection control and set to 100% in the absence of TTP for each cell line. Bars represent the mean values, error bars represent standard deviations, and the blue dots represent the individual points from three independent experiments. (B) Western blot analysis showing the expression of the proteins used in the complementation assay. Note that TTP ΔCIM is stabilized in GIGYF1/2 knockout cells expressing GIGYF wild type or WFF*. However, repression did not correlate with TTP levels but with the coexpression of a functional repressor complex. (C) DDX6 complexes involved in translational repression and mRNA decay. GIGYF1/2, 4E-T, PatL1, EDC3, and LSM14A assemble mutually exclusive complexes with DDX6. NOT1 associates with a different surface of DDX6, but a ternary complex forms only in the presence of 4E-T and possibly GIGYF1/2. Thus, DDX6 serves as a molecular adaptor for the assembly of protein complexes with distinct molecular roles—translational repression versus decapping. Independently of DDX6, 4E-T and GIGYF1/2 bind to NOT1, 4EHP, and PatL1. 4E-T is also an eIF4E- and an LSM14A-binding protein.

Recruitment of DDX6 by Hs GIGYF2 contributes to TTP-mediated translational repression of an ARE mRNA reporter. (A) Control or GIGYF1/2-null HEK293T cells (knockout [KO]) were transfected with the R-Luc-ARE-A90-MALAT1 reporter and plasmids expressing wild type (WT) or the indicated GIGYF2 mutants, HA-4EHP, and HA-TTP ΔCIM (Fabian et al. 2013). An F-Luc-GFP reporter served as a transfection control. R-Luc activity was normalized to that of the F-Luc transfection control and set to 100% in the absence of TTP for each cell line. Bars represent the mean values, error bars represent standard deviations, and the blue dots represent the individual points from three independent experiments. (B) Western blot analysis showing the expression of the proteins used in the complementation assay. Note that TTP ΔCIM is stabilized in GIGYF1/2 knockout cells expressing GIGYF wild type or WFF*. However, repression did not correlate with TTP levels but with the coexpression of a functional repressor complex. (C) DDX6 complexes involved in translational repression and mRNA decay. GIGYF1/2, 4E-T, PatL1, EDC3, and LSM14A assemble mutually exclusive complexes with DDX6. NOT1 associates with a different surface of DDX6, but a ternary complex forms only in the presence of 4E-T and possibly GIGYF1/2. Thus, DDX6 serves as a molecular adaptor for the assembly of protein complexes with distinct molecular roles—translational repression versus decapping. Independently of DDX6, 4E-T and GIGYF1/2 bind to NOT1, 4EHP, and PatL1. 4E-T is also an eIF4E- and an LSM14A-binding protein.

Concluding remarks

In this study, we showed that GIGYF proteins interact directly with the RNA-dependent ATPase DDX6 via a short motif. This interaction is mutually exclusive with other DDX6-binding partners such as 4E-T, EDC3, LSM14A, and PatL1 and has an important functional role in posttranscriptional regulation (Fig. 4C). We showed that GIGYF2 is a direct link between DDX6 and TTP, which explains at the molecular level why DDX6 is required for ARE mRNA translational repression (Qi et al. 2012). The GIGYF–4EHP complex can also be part of TTP-independent mRNPs via direct mRNA binding (Amaya Ramirez et al. 2018) or the interaction with ZNF598 and TNRC6 proteins (Morita et al. 2012; Schopp et al. 2017) . As the latter are important in ribosome quality control (Garzia et al. 2017; Sundaramoorthy et al. 2017; Juszkiewicz et al. 2018) and miRNA-mediated gene silencing (Chapat et al. 2017), respectively, the control of mRNA expression by the 4EHP–GIGYF–DDX6 complex is relevant for a wide range of cellular transcripts. Furthermore, as all of the components of the complex have been implicated to function in miRNA-mediated translational repression (Chen et al. 2014; Mathys et al. 2014; Chapat et al. 2017; Schopp et al. 2017), the 4EHP–GIGYF–DDX6 complex is likely to have an important role in miRNA-mediated mechanisms.

Materials and methods

DNA constructs

The DNA constructs used in this study are described in the Supplemental Material and listed in Supplemental Table S2. All of the constructs and mutations were confirmed by sequencing.

Protein production and purification

The experimental procedures for the production and purification of recombinant proteins are described in the Supplemental Material.

Crystallization, data collection, and structure determination

Detailed descriptions of the crystallization conditions and of the structure determination are in the Supplemental Material.

Co-IP assays and Western blotting

Co-IP assays in HEK293T and Schneider S2 cells were performed in the presence of RNase A as described previously (Peter et al. 2015a). All Western blots were developed using the ECL Western blotting detection system (GE Healthcare). The antibodies used in this study are listed in Supplemental Table S3.

Pull-down assays

The in vitro pull-down assays were performed as described previously (Igreja et al. 2014; Peter et al. 2015a,b). The details are in the Supplemental Material.

Complementation assay

HEK293T cells (wild-type or GIGYF1/2-null cells) were seeded in six-well plates (0.6 × 106 cells per well) and transfected using Lipofectamine 2000 (Invitrogen). The transfection mixtures contained 1 µg of the R-Luc reporters and 0.25 µg of the F-Luc control in the presence of 50 ng of λN-HA-TTP ΔCIM, 0.2 µg of GFP-MBP, 1 µg of GFP-GIGYF2 (wild type or mutants), or 0.5 µg of λN-HA-4EHP. F-Luc and R-Luc activities were measured 2 d after transfection using the dual-luciferase reporter assay system (Promega). R-Luc activity was normalized to that of the F-Luc control and set to 100% in the absence of TTP in wild-type and GIGYF1/2-null cells. Total RNA was isolated using TriFast (Peqlab Biotechnologies), and the RNA samples were analyzed by Northern blot as described previously (Behm-Ansmant et al. 2006).

Data availability

Atomic coordinates and structure factors have been deposited in the Protein Data Bank under the accession codes 6S8R (Dm Me31B-GIGYF) and 6S8S (Hs DDX6-EDC3).
  38 in total

1.  Similar modes of interaction enable Trailer Hitch and EDC3 to associate with DCP1 and Me31B in distinct protein complexes.

Authors:  Felix Tritschler; Ana Eulalio; Sigrun Helms; Steffen Schmidt; Murray Coles; Oliver Weichenrieder; Elisa Izaurralde; Vincent Truffault
Journal:  Mol Cell Biol       Date:  2008-09-02       Impact factor: 4.272

2.  A new paradigm for translational control: inhibition via 5'-3' mRNA tethering by Bicoid and the eIF4E cognate 4EHP.

Authors:  Park F Cho; Francis Poulin; Yoon Andrew Cho-Park; Ian B Cho-Park; Jarred D Chicoine; Paul Lasko; Nahum Sonenberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

3.  The DEAD-Box Protein Dhh1p Couples mRNA Decay and Translation by Monitoring Codon Optimality.

Authors:  Aditya Radhakrishnan; Ying-Hsin Chen; Sophie Martin; Najwa Alhusaini; Rachel Green; Jeff Coller
Journal:  Cell       Date:  2016-09-15       Impact factor: 41.582

4.  DDX6 Orchestrates Mammalian Progenitor Function through the mRNA Degradation and Translation Pathways.

Authors:  Ying Wang; Marc Arribas-Layton; Yifang Chen; Jens Lykke-Andersen; George L Sen
Journal:  Mol Cell       Date:  2015-09-24       Impact factor: 17.970

5.  Structural analysis of the yeast Dhh1-Pat1 complex reveals how Dhh1 engages Pat1, Edc3 and RNA in mutually exclusive interactions.

Authors:  Humayun Sharif; Sevim Ozgur; Kundan Sharma; Claire Basquin; Henning Urlaub; Elena Conti
Journal:  Nucleic Acids Res       Date:  2013-07-12       Impact factor: 16.971

6.  Human 4E-T represses translation of bound mRNAs and enhances microRNA-mediated silencing.

Authors:  Anastasiia Kamenska; Wei-Ting Lu; Dorota Kubacka; Helen Broomhead; Nicola Minshall; Martin Bushell; Nancy Standart
Journal:  Nucleic Acids Res       Date:  2013-12-13       Impact factor: 16.971

7.  The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.

Authors:  Aitor Garzia; Seyed Mehdi Jafarnejad; Cindy Meyer; Clément Chapat; Tasos Gogakos; Pavel Morozov; Mehdi Amiri; Maayan Shapiro; Henrik Molina; Thomas Tuschl; Nahum Sonenberg
Journal:  Nat Commun       Date:  2017-07-07       Impact factor: 14.919

8.  Direct role for the Drosophila GIGYF protein in 4EHP-mediated mRNA repression.

Authors:  Vincenzo Ruscica; Praveen Bawankar; Daniel Peter; Sigrun Helms; Cátia Igreja; Elisa Izaurralde
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

9.  4E-BPs require non-canonical 4E-binding motifs and a lateral surface of eIF4E to repress translation.

Authors:  Cátia Igreja; Daniel Peter; Catrin Weiler; Elisa Izaurralde
Journal:  Nat Commun       Date:  2014-09-02       Impact factor: 14.919

10.  Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements.

Authors:  Rui Fu; Myanna T Olsen; Kristofor Webb; Eric J Bennett; Jens Lykke-Andersen
Journal:  RNA       Date:  2016-01-13       Impact factor: 4.942

View more
  7 in total

1.  Distinct elongation stalls during translation are linked with distinct pathways for mRNA degradation.

Authors:  Anthony J Veltri; Karole N D'Orazio; Laura N Lessen; Raphael Loll-Krippleber; Grant W Brown; Rachel Green
Journal:  Elife       Date:  2022-07-27       Impact factor: 8.713

2.  4EHP and GIGYF1/2 Mediate Translation-Coupled Messenger RNA Decay.

Authors:  Ramona Weber; Min-Yi Chung; Csilla Keskeny; Ulrike Zinnall; Markus Landthaler; Eugene Valkov; Elisa Izaurralde; Cátia Igreja
Journal:  Cell Rep       Date:  2020-10-13       Impact factor: 9.423

3.  microRNA-mediated translation repression through GYF-1 and IFE-4 in C. elegans development.

Authors:  Vinay K Mayya; Mathieu N Flamand; Alice M Lambert; Seyed Mehdi Jafarnejad; James A Wohlschlegel; Nahum Sonenberg; Thomas F Duchaine
Journal:  Nucleic Acids Res       Date:  2021-05-21       Impact factor: 16.971

Review 4.  Cancer Plasticity: The Role of mRNA Translation.

Authors:  Laura J Lee; David Papadopoli; Michael Jewer; Sonia Del Rincon; Ivan Topisirovic; Mitchell G Lawrence; Lynne-Marie Postovit
Journal:  Trends Cancer       Date:  2020-10-13

Review 5.  Eukaryotic mRNA Decapping Activation.

Authors:  Elva Vidya; Thomas F Duchaine
Journal:  Front Genet       Date:  2022-03-23       Impact factor: 4.599

6.  SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.

Authors:  Zhang Xu; Jung-Hyun Choi; David L Dai; Jun Luo; Reese Jalal Ladak; Qian Li; Yimeng Wang; Christine Zhang; Shane Wiebe; Alex C H Liu; Xiaozhuo Ran; Jiaqi Yang; Parisa Naeli; Aitor Garzia; Lele Zhou; Niaz Mahmood; Qiyun Deng; Mohamed Elaish; Rongtuan Lin; Lara K Mahal; Tom C Hobman; Jerry Pelletier; Tommy Alain; Silvia M Vidal; Thomas Duchaine; Mohammad T Mazhab-Jafari; Xiaojuan Mao; Seyed Mehdi Jafarnejad; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-25       Impact factor: 12.779

7.  me31B regulates stem cell homeostasis by preventing excess dedifferentiation in the Drosophila male germline.

Authors:  Lindy Jensen; Zsolt G Venkei; George J Watase; Bitarka Bisai; Scott Pletcher; Cheng-Yu Lee; Yukiko M Yamashita
Journal:  J Cell Sci       Date:  2021-07-22       Impact factor: 5.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.